QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
NASDAQ:HSKA

Heska - HSKA Stock Forecast, Price & News

$86.29
-2.19 (-2.48%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$85.92
$89.70
50-Day Range
$60.21
$93.15
52-Week Range
$57.83
$154.85
Volume
134,360 shs
Average Volume
138,432 shs
Market Capitalization
$934.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$123.00

Heska MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
42.5% Upside
$123.00 Price Target
Short Interest
Healthy
4.52% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.75mentions of Heska in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$851,037 Bought Last Quarter
Proj. Earnings Growth
120.00%
From $0.30 to $0.66 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.76 out of 5 stars

Medical Sector

41st out of 1,027 stocks

Diagnostic Substances Industry

2nd out of 15 stocks

HSKA stock logo

About Heska (NASDAQ:HSKA) Stock

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the North America and International segments. The North America segment includes the United States, Canada, and Mexico. The International segment involves Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Receive HSKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heska and its competitors with MarketBeat's FREE daily newsletter.

HSKA Stock News Headlines

A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
Heska (HSKA) Moves 9.0% Higher: Will This Strength Last?
Heska Corporation Reports Third Quarter 2022 Results
New "Vertical" Technology Solves Solar Power's Major Flaw
Even conservationists hate conventional solar farms. That's because they take up too much land and can degrade the environment. And let's face it, land is expensive...Fortunately, new groundbreaking tower technology solves solar's #1 drawback. These unique vertical structures not only take up to 90% less land space, but also generate extra electric power.
Heska (HSKA) Q3 Earnings and Revenues Lag Estimates
See More Headlines
Receive HSKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heska and its competitors with MarketBeat's FREE daily newsletter.

HSKA Company Calendar

Last Earnings
11/08/2022
Today
2/06/2023
Next Earnings (Estimated)
2/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HSKA
Employees
655
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$123.00
High Stock Price Forecast
$165.00
Low Stock Price Forecast
$58.00
Forecasted Upside/Downside
+42.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-1,150,000.00
Pretax Margin
-7.34%

Debt

Sales & Book Value

Annual Sales
$253.74 million
Cash Flow
$1.02 per share
Book Value
$40.69 per share

Miscellaneous

Free Float
9,635,000
Market Cap
$934.52 million
Optionable
Not Optionable
Beta
1.54

Key Executives

  • Kevin S. WilsonKevin S. Wilson
    President, Chief Executive Officer & Director
  • Nancy Wisnewski
    Chief Operating Officer & Executive Vice President
  • Catherine I. GrassmanCatherine I. Grassman
    Chief Financial Officer & Executive Vice President
  • Glenn R. Frank
    Vice President-Research & Development
  • Steven M. Eyl
    Chief Commercial Officer & Executive VP













HSKA Stock - Frequently Asked Questions

Should I buy or sell Heska stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Heska in the last twelve months. There are currently 1 sell rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HSKA shares.
View HSKA analyst ratings
or view top-rated stocks.

What is Heska's stock price forecast for 2023?

4 Wall Street research analysts have issued 12-month price objectives for Heska's stock. Their HSKA share price forecasts range from $58.00 to $165.00. On average, they expect the company's stock price to reach $123.00 in the next twelve months. This suggests a possible upside of 42.5% from the stock's current price.
View analysts price targets for HSKA
or view top-rated stocks among Wall Street analysts.

How have HSKA shares performed in 2023?

Heska's stock was trading at $62.16 at the beginning of 2023. Since then, HSKA shares have increased by 38.8% and is now trading at $86.29.
View the best growth stocks for 2023 here
.

When is Heska's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our HSKA earnings forecast
.

How were Heska's earnings last quarter?

Heska Co. (NASDAQ:HSKA) announced its quarterly earnings results on Tuesday, November, 8th. The medical research company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.09 by $0.15. The medical research company earned $61.49 million during the quarter, compared to analyst estimates of $69.72 million. Heska had a positive trailing twelve-month return on equity of 0.09% and a negative net margin of 6.26%.

What guidance has Heska issued on next quarter's earnings?

Heska issued an update on its FY 2022 earnings guidance on Thursday, December, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $266.43 million-$266.43 million, compared to the consensus revenue estimate of $272.89 million.

What is Kevin S. Wilson's approval rating as Heska's CEO?

5 employees have rated Heska Chief Executive Officer Kevin S. Wilson on Glassdoor.com. Kevin S. Wilson has an approval rating of 57% among the company's employees. This puts Kevin S. Wilson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Heska own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Heska investors own include Gilead Sciences (GILD), Exxon Mobil (XOM), Netflix (NFLX), Biogen (BIIB), AbbVie (ABBV), Amgen (AMGN), Broadcom (AVGO), Alibaba Group (BABA), Exelixis (EXEL) and Merck & Co., Inc. (MRK).

What is Heska's stock symbol?

Heska trades on the NASDAQ under the ticker symbol "HSKA."

Who are Heska's major shareholders?

Heska's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (2.92%), Assenagon Asset Management S.A. (1.18%), Manning & Napier Group LLC (0.62%), Rice Hall James & Associates LLC (0.42%), Monarch Partners Asset Management LLC (0.24%) and Yousif Capital Management LLC (0.06%). Insiders that own company stock include Bonnie J Trowbridge, Catherine Grassman, Jason D Aroesty, Kevin S Wilson, Nancy Wisnewski and Sharon J Larson.
View institutional ownership trends
.

How do I buy shares of Heska?

Shares of HSKA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Heska's stock price today?

One share of HSKA stock can currently be purchased for approximately $86.29.

How much money does Heska make?

Heska (NASDAQ:HSKA) has a market capitalization of $934.52 million and generates $253.74 million in revenue each year. The medical research company earns $-1,150,000.00 in net income (profit) each year or ($1.57) on an earnings per share basis.

How many employees does Heska have?

The company employs 655 workers across the globe.

How can I contact Heska?

Heska's mailing address is 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538. The official website for the company is www.heska.com. The medical research company can be reached via phone at (970) 493-7272, via email at investorrelations@heska.com, or via fax at 970-619-3003.

This page (NASDAQ:HSKA) was last updated on 2/6/2023 by MarketBeat.com Staff